XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Cash flows from operating activities:    
Net income $ 4,418 $ 5,705
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 4,657 4,582
Transactional losses/(gains) 1,400 (75)
Provision for inventories and accounts receivable 2,548 2,292
Deferred income taxes (1,209) (553)
Stock-based compensation 2,234 2,855
Other 652 171
Changes in assets and liabilities:    
Trade receivables 4,838 (2,261)
Inventories (44,369) (32,298)
Other current assets (239) (8,375)
Accounts payable (705) 3,493
Accrued liabilities 15,954 6,108
Accrued payroll and benefits 3,199 618
Income taxes receivable 1,137 4,508
Income taxes payable (6,177) (22,962)
Other non-current assets 580 276
Other non-current liabilities 66 6
Net cash used in operating activities (11,016) (35,910)
Cash flows from investing activities:    
Capital expenditures (2,826) (3,913)
Long-term investments (1,887) (4,310)
Trademarks and other intangibles (41) (82)
Net cash used in investing activities (4,754) (8,305)
Cash flows from financing activities:    
Dividends paid (15,557) (15,547)
Stock repurchases (1,594) (1,086)
Stock awards and options exercised and other changes (467) (1,075)
Net cash used in financing activities (17,618) (17,708)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 5,467 (1,900)
Net decrease in cash, cash equivalents and restricted cash (27,921) (63,823)
Cash, cash equivalents, and restricted cash at beginning of year 209,214 262,814
Cash, cash equivalents, and restricted cash at end of period 181,293 198,991
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 180,493 198,251
Restricted cash included in other non-current assets 800 740
Cash, cash equivalents, and restricted cash at end of period $ 181,293 $ 198,991